Total assets increased 29.0%
Total assets changed +29.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +29.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed +60.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed -100.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +96.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +1778 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +68.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +37.0% from the comparable as-filed period.
Free-cash-flow proxy changed +42.0% from the comparable as-filed period.
Net income changed -55.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +2048 basis points from the comparable as-filed period.
Operating cash flow changed +48.5% from the comparable as-filed period.
Gross margin changed +239 basis points from the comparable as-filed period.
Cash & equivalents changed +293.6% from the comparable as-filed period.
Revenue changed +21.5% from the comparable as-filed period.
Gross debt changed -100.0% from the comparable as-filed period.
Shares outstanding changed +4.8% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
SBC / revenue changed -715 basis points from the comparable as-filed period.
Current long-term debt changed -100.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +80.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -20.6% from the comparable as-filed period.
Trade receivables changed +11.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +1162 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1217 basis points from the comparable as-filed period.
R&D / revenue changed -1422 basis points from the comparable as-filed period.
Inventory changed +24.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Debt / assets changed -2689 basis points from the comparable as-filed period.
Debt / revenue changed -22685 basis points from the comparable as-filed period.
Receivables / revenue changed -602 basis points from the comparable as-filed period.
Stock-based compensation changed -16.8% from the comparable as-filed period.
Capex / revenue changed +54 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +12.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net debt changed -287.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed +40 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed -4.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.